Short communication · 4 Aug 2026
Conference abstractPublished 14 Apr 2014
Serum mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Chagas disease is endemic in Latin America and an emerging infectious disease in the US. No effective treatments are available. TcG1, TcG2 and TcG4 antigens are highly conserved in clinically-relevant Trypanosomacruzi (Tc) isolates, and recognized by B and T cells in infected host. Delivery of these antigens as a DNA-prime/protein-boost vaccine (TcVac2) elicited lytic antibodies and type 1 CD8+T cells that expanded upon challenge infection, and provided >90% control of parasite burden and myocarditis in chagasic mice and dogs. Here in, we determined if peripheral blood can be utilized to capture the TcVac2-induced protection from Chagas disease. We evaluated the sera levels of TckDNA/Tc18SrDNA and murine mitochondrial DNA (mtDNA) as indicators of parasite persistence and tissue damage; and effect of sera on macrophage phenotype. Circulating TckDNA/Tc18SrDNA and mtDNA were decreased by >3-5-fold and 2-fold, respectively, in vaccinated/ infected mice as compared to non-vaccinated/infected mice. Macrophages incubated with sera from vaccinated/infected mice exhibited M2 surface markers (CD16, CD32, CD200 and CD206), moderate proliferation, low oxidative/nitrosative burst, and regulatory/anti-inflammatory cytokine (IL-4+IL-10>TNF-α) response. In comparison, macrophages incubated with sera from non-vaccinated/infected mice exhibited M1 surface markers, vigorous proliferation, substantial oxidative/nitrosative burst, and proinflammatory cytokine (TNF-α>>IL-4+IL-10) response. Cardiac infiltration of macrophages and TNF-α and oxidant levels were significantly reduced in TcVac2-immunized chagasic mice. Conclusion: Circulating TcDNA and mtDNA levels and macrophage phenotype mediated by sera constituents reflects in vivo levels of parasite persistence, tissue damage and inflammatory/anti-inflammatory state; and have potential utility in evaluating disease severity and efficacy of vaccines and drug therapies.
Subjects
CardiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical and Experimental Cardiology.
Conference abstract · 15 Jun 2026
Speckle Tracking Echocardiography for Early Identification of Chemotherapy-Induced Cardiotoxicity
Conference abstract · 15 Jun 2026
Coronary CT Angiography as a First-Line Diagnostic Tool for Stable Chest Pain: Clinical Outcomes from a Multicenter Study
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical and Experimental Cardiology
- SubjectCardiology
- BylineArticles whose byline prints “Nisha Jain Garg”
- BylineArticles whose byline prints “Shivali Gupta”
- BylineArticles whose byline prints “Jessica E. Osizugbo”
- BylineArticles whose byline prints “Trevor S Silva”
